Formac Pharmaceuticals and Flamac announce the development and validation of a high-throughput platform for the accelerated screening of silica-based drug delivery materials.
After a two- year collaborative research project, a high-throughput screening platform has been developed. The platform was installed and validated at Formac’s research facilities in Leuven, Belgium.
Formac owns a number of patents in the field of silica-based drug delivery technologies, and the use of the high-throughput system allows for the identification of optimal silica-drug combinations.
Release Date: May 12, 2011
Source: Formac Pharmaceuticals